NDC 57894-225 – Inlexzo
Gemcitabine 225 mg/1 · System · Intravesical
Product NDC57894-225
Product details
- Brand name
- Inlexzo
- Generic name
- Gemcitabine intravesical
- Labeler
- Janssen Biotech, Inc
- Dosage form
- System
- Route
- Intravesical
- Marketing category
- NDA · NDA219683
- Marketed since
- September 14, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Gemcitabine 225 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 57894-225-01 | 1 SYSTEM in 1 BOX (57894-225-01) | Sep 14, 2025 |
| 57894-225-99 sample | 1 SYSTEM in 1 BOX (57894-225-99) | Sep 14, 2025 |